Recall Or Safety Alert for Consoles of intra-aortic counterpulsation (BCIA), distributed between 4-03-2003 and 16-6-2017: • CS100i BCIA, reference 0998-UC-0446HXX; 0998-UC-0479HXX • CS100 BCIA, reference 0998-00-3013-XX; 0998-UC-3013-XX • CS300 BCIA, reference 0998-00-3023

According to Agencia Española de Medicamentos y Productos Sanitarios (Via FOI), this recall or safety alert involved a device in Spain that was produced by N/A.

What is this?

Alerts provide important information and recommendations about products. Even though an alert has been issued, it does not necessarily mean a product is considered to be unsafe. Safety Alerts, addressed to health workers and users, may include recalls. They can be written by manufacturers, but also by health officials.

Learn more about the data here
  • Type of Event
    Recall / Safety Alert
  • Date
  • Event Country
  • Event Source
  • Event Source URL
  • Notes / Alerts
    The data from Spain is current through June 2018. All of the data comes from Agencia Española de Medicamentos y Productos Sanitarios, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Spain.
  • Extra notes in the data
  • Action
    Safety warnings due to the risk of occurrence: • A false blood detection alarm. • Penetration of liquids in the BCIA that affects the initiation or continuation of the therapy.


  • Source